The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
GPR41 and GPR43 are related members of a homologous family of orphan G protein-coupled receptors that are tandemly encoded at a single chromosomal locus in both humans and mice. We identified the acetate anion as an agonist of human GPR43 during routine ligand bank screening in yeast. This activity was confirmed after transient transfection of GPR43 into mammalian cells using Ca(2+) mobilization and [(35)S]guanosine 5'-O-(3-thiotriphosphate) binding assays and by coexpression with GIRK G protein-regulated potassium channels in Xenopus laevis oocytes. Other short chain carboxylic acid anions such as formate, propionate, butyrate, and pentanoate also had agonist activity. GPR41 is related to GPR43 (52% similarity; 43% identity) and was activated by similar ligands but with differing specificity for carbon chain length, with pentanoate being the most potent agonist. A third family member, GPR42, is most likely a recent gene duplication of GPR41 and may be a pseudogene. GPR41 was expressed primarily in adipose tissue, whereas the highest levels of GPR43 were found in immune cells. The identity of the cognate physiological ligands for these receptors is not clear, although propionate is known to occur in vivo at high concentrations under certain pathophysiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Molecular data showed that acetate, propionate, and butyrate can preferentially activate a series of free fatty acid receptors (FFARs) to increase energy harvest and triglyceride storage in adipose tissue [34,35,36].”
From Preventive Effects and Mechanisms of Garlic on Dyslipidemia and Gut Microbiome Dysbiosis (2019) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can activate several G-protein coupled receptors (GPCR), of which free fatty acid receptor 2 (FFAR2, also referred to as GPR43) and 3 (FFAR3, also referred to as GPR41) are the most investigated (Brown et al., 2003;Le Poul et al., 2003;Nilsson et al., 2003).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Brown et al., 2003
Experimental — accuracy not yet measuredIn the citing paper
“As most SCFAs have agonist activity for GPR41 and GPR4341”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
The Genome Sequence of Drosophila melanogaster
Adams, M. D., Celniker, S. E., Holt, R. A., Evans, C. A., Gocayne, J. D., Amanatides, P. G., Scherer, S. E., Li, P. W., Hoskins, R. A., Galle, R. F., et al. (2000) · Science · doi:10.1126/science.287.5461.2185 · Cited by 5,929
Genome Sequence of the Nematode C. elegans : A Platform for Investigating Biology
The C. elegans Sequencing Consortium* (1998) · Science · doi:10.1126/science.282.5396.2012 · Cited by 4,485
Mumberg, D., Müller, R., & Funk, M. (1995) · Gene · doi:10.1016/0378-1119(95)00037-7 · Cited by 1,957
Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.-X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9489 · Cited by 1,685
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Self-citationA G Protein-coupled Receptor for UDP-glucose
Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10767 · Cited by 342
Self-citation
Research works printed but not linked: 1
- Rammal, 1991, Onkologie, 14, 130
Cited by
Items 101–200 of 1,005
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
“Intracellularly, GPCR activation is translated into various signals mediated via heterotrimeric G proteins, arrestins (Luttrell et al., 1999), kinases (Benovic et al., 1989), ion channels, and various scaffolding proteins (Brown et al., 2003) (Figure 1).”
BackgroundThe Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.002 · Cited by 555
“Preclinical evidence suggests that SCFAs may act as a key signaling metabolite, regulating microbiotainfluenced BBB development and maintenance through epigenetic modification.(42,43) Lipopolysaccharides also may play a role, although likely amore limited one, in disrupting the BBB through systemic immune activation.”
BackgroundShort-chain fatty acids as potential regulators of skeletal muscle metabolism and function
Frampton, J., Murphy, K. G., Frost, G., & Chambers, E. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0188-7 · Cited by 516
Specialized metabolites from the microbiome in health and disease
Sharon, G., Garg, N., Debelius, J., Knight, R., Dorrestein, P. C., & Mazmanian, S. K. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.016 · Cited by 544
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
Ratajczak, W., Rył, A., Mizerski, A., Walczakiewicz, K., Sipak, O., & Laszczyńska, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2648 · Cited by 514
Hays, K. E., Pfaffinger, J. M., & Ryznar, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 453
“58 The receptor Olfr78 in mice, OR51E2 59 being the human equivalent, mainly binds acetate and propionate and is expressed on vascular smooth muscle cells of peripheral vasculature and the renal afferent arteriole.”
BackgroundGérard, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2061-5 · Cited by 508
“FFAR2 is preferentially activated by acetate, and FFAR3 by butyrate, whereas propionate activates both receptors [48].”
BackgroundHan, J., Lin, K., Sequeira, C., & Borchers, C. H. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.11.015 · Cited by 521
Zhao, Y., Chen, F., Wu, W., Sun, M., Bilotta, A. J., Yao, S., Xiao, Y., Huang, X., Eaves-Pyles, T. D., Golovko, G., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.118 · Cited by 515
“GPR41 and GPR43 are two major host receptors for most SCFA.(15) SCFA can also inhibit histone deacetylase activity (HDAC) to downregulate macrophage pro-inflammatory cytokine production and activate peroxisome proliferator-activated receptor g to stimulate human colonic epithelial cell expression of angiopoietin-like…”
InfluentialMcNabney, S., & Henagan, T. (2017) · Nutrients · doi:10.3390/nu9121348 · Cited by 508
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 497
The role of the microbiome in NAFLD and NASH
Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809302 · Cited by 523
“While GPR41 binds propionate and GPR43 primarily recognizes acetate, both can also bind all other SCFAs with lower affinity (Brown et al , 2003).”
Zhang, L. S., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 500
“Synthesized predominantly via succinate pathway [36] Propionibacterium Bacteroides Negativicutes, Selenomonas ruminantium, Roseburia inulinivorans Escherichia coli Activates GPR41 [89] and GPR43 [38, 39]”
BackgroundInfluentialGill, P. A., van Zelm, M. C., Muir, J. G., & Gibson, P. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14689 · Cited by 520
“GPR43 may be activated by acetate and propionate at an effective half-maximal concentration (EC50) of approximately 50-200 lmol/ L, depending on the expression system and cell line used.(79,83) Propionate can activate GPR41 with an EC50 of 10 lmol/L.”
BackgroundGut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion
Andrade-Oliveira, V., Amano, M. T., Correa-Costa, M., Castoldi, A., Felizardo, R. J. F., de Almeida, D. C., Bassi, E. J., Moraes-Vieira, P. M., Hiyane, M. I., Rodas, A. C. D., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030288 · Cited by 502
Wu, W., Sun, M., Chen, F., Cao, A. T., Liu, H., Zhao, Y., Huang, X., Xiao, Y., Yao, S., Zhao, Q., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.114 · Cited by 500
“butyrate are the most potent agonists for GPR41, but weak agonists for GPR43, acetate is the potent agonist for GPR43, but a weak agonist for GPR41.(25) SCFA-GPR43 interaction has been implicated in regulating intestinal inflammatory responses and other inflammatory diseases.”
BackgroundGe, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., & Li, Y. (2008) · Endocrinology · doi:10.1210/en.2008-0059 · Cited by 475
“In addition, C2 (acetate) and C3 (propionate) are the most potent activators of GPR43, whereas C2 is not as potent as C3, C4, or C5 in activating GPR41 (5, 6).”
BackgroundInfluentialMaternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice
Kimura, I., Miyamoto, J., Ohue-Kitano, R., Watanabe, K., Yamada, T., Onuki, M., Aoki, R., Isobe, Y., Kashihara, D., Inoue, D., et al. (2020) · Science · doi:10.1126/science.aaw8429 · Cited by 485
“A. J. Brown et al., The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.”
BackgroundInfluentialMicrobiome, metabolites and host immunity
Levy, M., Blacher, E., & Elinav, E. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.10.003 · Cited by 484
The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut
Yoo, B. B., & Mazmanian, S. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.011 · Cited by 474
“G-protein-coupled receptors 41 and 43 (GPR41 and GPR43, respectively) are activated by acetate and propionate (Brown et al., 2003; Tazoe et al., 2008), whereas GPR109A is specific to butyrate (Thangaraju et al., 2009).”
BackgroundSCFAs strongly stimulate PYY production in human enteroendocrine cells
Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., & Blottiere, H. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18259-0 · Cited by 450
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482
“The latter is then transferred back to neurons [126].”
BackgroundZeng, H., Umar, S., Rust, B., Lazarova, D., & Bordonaro, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051214 · Cited by 480
Agus, A., Denizot, J., Thévenot, J., Martinez-Medina, M., Massier, S., Sauvanet, P., Bernalier-Donadille, A., Denis, S., Hofman, P., Bonnet, R., et al. (2016) · Scientific Reports · doi:10.1038/srep19032 · Cited by 477
Microbiota-Derived Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial Development
Lee, Y.-S., Kim, T.-Y., Kim, Y., Lee, S.-H., Kim, S., Kang, S. W., Yang, J.-Y., Baek, I.-J., Sung, Y. H., Park, Y.-Y., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.11.002 · Cited by 459
Karaki, S.-I., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J. B., & Kuwahara, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0140-x · Cited by 460
“In 2003, two orphan G-protein coupled receptors, GPR41 and GPR43, were discovered to be receptors for SCFAs (Brown et al. 2003; Le Poul et al. 2003).”
BackgroundAkkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How?
Geerlings, S. Y., Kostopoulos, I., De Vos, W. M., & Belzer, C. (2018) · Microorganisms · doi:10.3390/microorganisms6030075 · Cited by 446
Hodgkinson, K., El Abbar, F., Dobranowski, P., Manoogian, J., Butcher, J., Figeys, D., Mack, D., & Stintzi, A. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.10.024 · Cited by 423
Regulation of short-chain fatty acids in the immune system
Liu, X.-F., Shao, J.-H., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-J., Liu, Z.-Z., He, D.-D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 403
“Increased intracellular cAMP levels facilitate the entry of intracellular calcium ions into the cytoplasm, a process that regulates gene transcription and translation in immune cells (43) (Figure 1).”
BackgroundShort-chain fatty acids in control of energy metabolism
Hu, J., Lin, S., Zheng, B., & Cheung, P. C. K. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1245650 · Cited by 441
“Since the discovery of SCFAs sensing receptors (GPR41 and GPR43) in the early 21st century (Brown et al., 2003), SCFAs have been regarded as the signalling molecules involved in various cellular processes.”
BackgroundMetabolites: messengers between the microbiota and the immune system
Levy, M., Thaiss, C. A., & Elinav, E. (2016) · Genes & Development · doi:10.1101/gad.284091.116 · Cited by 439
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137379 · Cited by 384
“Previous studies have indicated that GPR43 is expressed extensively in immune tissues such as the spleen and in immune cells such as neutrophils [28,42], indicating that SCFAs play an important role in immune responses.”
BackgroundInfluentialButyrate and other short-chain fatty acids as modulators of immunity: What relevance for health?
Meijer, K., de Vos, P., & Priebe, M. G. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833eebe5 · Cited by 443
Boets, E., Gomand, S. V., Deroover, L., Preston, T., Vermeulen, K., De Preter, V., Hamer, H. M., Van den Mooter, G., De Vuyst, L., Courtin, C. M., et al. (2017) · The Journal of Physiology · doi:10.1113/jp272613 · Cited by 443
“In addition, they affect gut and host metabolism by activating the G-protein coupled cell surface receptors GPR-41 and GPR-43 (Brown et al. 2003), later renamed as free fatty acid receptors (FFAR)-3 and FFAR-2, which are involved in the regulation of glucose and lipid metabolism (den Besten et al. 2013b).”
InfluentialNatarajan, N., Hori, D., Flavahan, S., Steppan, J., Flavahan, N. A., Berkowitz, D. E., & Pluznick, J. L. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2016 · Cited by 441
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Fock, E., & Parnova, R. (2023) · Cells · doi:10.3390/cells12040657 · Cited by 385
“For GPR41 activation, propionate was the most potent, whereas for GPR43, propionate and acetate were equally potent and more effective than butyrate [16,87].”
BackgroundInfluentialMedium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84
Wang, J., Wu, X., Simonavicius, N., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608019200 · Cited by 417
de Wit, N., Derrien, M., Bosch-Vermeulen, H., Oosterink, E., Keshtkar, S., Duval, C., de Vogel-van den Bosch, J., Kleerebezem, M., Müller, M., & van der Meer, R. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00488.2011 · Cited by 428
Teame, T., Wang, A., Xie, M., Zhang, Z., Yang, Y., Ding, Q., Gao, C., Olsen, R. E., Ran, C., & Zhou, Z. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.570344 · Cited by 388
“SCFAs-promoting probiotic L. johnsonii L531 treatment have been shown to control Salmonella infection and maintaining metabolic homeostasis in pig (166).”
BackgroundInfluentialIslet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
“Other lipid-binding GPCRs are GPR41 (also known as FFAR3), GPR43 (also known as FFAR2) and GPR120 (Ref”
BackgroundMicrobiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
Christiansen, C. B., Gabe, M. B. N., Svendsen, B., Dragsted, L. O., Rosenkilde, M. M., & Holst, J. J. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2017 · Cited by 401
“found to signal exclusively through the G i pathway (8), which traditionally is linked to suppressed secretion (59).”
BackgroundInfluentialMacfarlane, G. T., & Macfarlane, S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822fecfe · Cited by 406
“Control 0 10.2 3.3 3.2 1.1 3 11.0 3.2 3.8 Not detected 12 16.4 4.7 3.9 Not detected FOS 0 10.2 3.3 3.2 1.1 3 19.7 5.8 12.6 30.1 12 140 32.4 50.5 Not detected GOS 0 10.2 3.3 3.2 1.1 3 23.5 7.8 11.0 14.7 12 148 34.9 42.3 1.8 Inulin 0 10.2 3.3 3.2 1.1 3 15.2 5.0 7.6 15.2 12 97.6 19.0 28.2 Not detected FOS indicates fruct…”
BackgroundInfluentialBriscoe, C. P., Peat, A. J., McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., McCoy, D. C., Kenakin, T. P., Andrews, J. L., Ammala, C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706770 · Cited by 400
Self-citationControl of lymphocyte functions by gut microbiota-derived short-chain fatty acids
Kim, C. H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00625-0 · Cited by 404
“Ffar2 and Ffar3 (GPR41) sense the presence of C2, C3, and C4 with somewhat different sensitivities.(82,83) The agonistic activity of C2 and C3 specific for Ffar2 starts at ~10 μM and peaks at 10 mM for Ffar2-overexpressing Chinese hamster ovary cells.”
BackgroundGonçalves, P., Araújo, J. R., & Di Santo, J. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 393
The gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403
“SCFAs bind to four receptors, the free fatty acid receptors GPR43 and GPR41 (also known as FFAR2 and FFAR3) (79), the niacin/butyrate receptor GPR109a (also known as HCA2) (80), and the olfactory receptor Olfr78 (81).”
BackgroundA neuroscientist's guide to lipidomics
Piomelli, D., Astarita, G., & Rapaka, R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2233 · Cited by 379
Khan, S., Moore, R. J., Stanley, D., & Chousalkar, K. K. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.00600-20 · Cited by 373
“, GPR41 and GPR43) to stimulate -defensins and RegIII (66).”
BackgroundDiet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
Enteroendocrine cells: a review of their role in brain–gut communication
Latorre, R., Sternini, C., De Giorgio, R., & Greenwood‐Van Meerveld, B. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12754 · Cited by 392
G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation
Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900063 · Cited by 376
Gut microbiota as the key controllers of 'healthy' aging of elderly people
Ragonnaud, E., & Biragyn, A. (2021) · Immunity & Ageing · doi:10.1186/s12979-020-00213-w · Cited by 383
Wlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., Russell, S. L., Vallance, B. A., & Finlay, B. B. (2011) · Infection and Immunity · doi:10.1128/iai.01104-10 · Cited by 382
“Degradation of these mucin peptides and O-linked glycans serves as an energy source for the intestinal microbiota and consequently results in the production of short-chain fatty acids such as acetate and butyrate (15, 25), which are able to diffuse through the inner mucus layer and stimulate the underlying epithelial…”
BackgroundThe Immunomodulatory Functions of Butyrate
Siddiqui, M. T., & Cresci, G. A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s300989 · Cited by 381
Butyrate in Energy Metabolism: There Is Still More to Learn
Zhang, L., Liu, C., Jiang, Q., & Yin, Y. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.12.003 · Cited by 364
Gut microbiota, enteroendocrine functions and metabolism
Cani, P. D., Everard, A., & Duparc, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.008 · Cited by 378
“However, the recent identification of a family of G protein coupled receptors (GPCRs) that bind these gut microbiome products has highlighted new potential mechanisms of action for SCFAs in glucose homeostasis [28].”
BackgroundShort-chain fatty acids act as antiinflammatory mediatorsby regulating prostaglandin E2 and cytokines
Cox, M. A., Jackson, J., Stanton, M., Rojas-Triana, A., Bober, L., Laverty, M., Yang, X., Zhu, F., Liu, J., Wang, S., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5549 · Cited by 377
“GPR41 is also expressed in immune cells, but at lower levels compared to GPR43 and thus may play a lesser role [ 8-10 ]”
Review of the relationships among polysaccharides, gut microbiota, and human health
Song, Q., Wang, Y., Huang, L., Shen, M., Yu, Y., Yu, Q., Chen, Y., & Xie, J. (2021) · Food Research International · doi:10.1016/j.foodres.2020.109858 · Cited by 357
Immune regulation by microbiome metabolites
Kim, C. H. (2018) · Immunology · doi:10.1111/imm.12930 · Cited by 375
A novel SCFA receptor, the microbiota, and blood pressure regulation
Pluznick, J. (2014) · Gut Microbes · doi:10.4161/gmic.27492 · Cited by 374
Bacterial Neuroactive Compounds Produced by Psychobiotics
Wall, R., Cryan, J. F., Ross, R. P., Fitzgerald, G. F., Dinan, T. G., & Stanton, C. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_10 · Cited by 353
Li, Y. J., Chen, X., Kwan, T. K., Loh, Y. W., Singer, J., Liu, Y., Ma, J., Tan, J., Macia, L., Mackay, C. R., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101029 · Cited by 368
Lack of beta-arrestin signaling in the absence of active G proteins
Grundmann, M., Merten, N., Malfacini, D., Inoue, A., Preis, P., Simon, K., Rüttiger, N., Ziegler, N., Benkel, T., Schmitt, N. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02661-3 · Cited by 358
Suzuki, T., Yoshida, S., & Hara, H. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508888733 · Cited by 355
“GPR43 has been reported to express in human and rat colon enterocytes((36,37)) and couple with Gq and Gi/o proteins((35)).”
BackgroundLi, M., van Esch, B. C. A. M., Henricks, P. A. J., Folkerts, G., & Garssen, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00533 · Cited by 351
“Their roles in endothelial activation remain unknown (Brown et al., 2003).”
BackgroundSoluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota
Guan, Z.-W., Yu, E.-Z., & Feng, Q. (2021) · Molecules · doi:10.3390/molecules26226802 · Cited by 336
“Therefore, GPR43 and GPR41 were also named FFAR (free fatty acid receptor) 2 and FFAR3, respectively [94].”
BackgroundMollica, M. P., Mattace Raso, G., Cavaliere, G., Trinchese, G., De Filippo, C., Aceto, S., Prisco, M., Pirozzi, C., Di Guida, F., Lama, A., et al. (2017) · Diabetes · doi:10.2337/db16-0924 · Cited by 356
“Butyrate exerts multiple effects by distinct mechanisms; in particular, it acts as a signal molecule, interacting with G protein–coupled receptors free fatty acid (FFA) receptor 2 and 3 (22).”
BackgroundNey, L.-M., Wipplinger, M., Grossmann, M., Engert, N., Wegner, V. D., & Mosig, A. S. (2023) · Open Biology · doi:10.1098/rsob.230014 · Cited by 315
Short chain fatty acids and their receptors: new metabolic targets
Layden, B. T., Angueira, A. R., Brodsky, M., Durai, V., & Lowe, W. L. (2013) · Translational Research · doi:10.1016/j.trsl.2012.10.007 · Cited by 357
“Asmentioned above, FFAR2 and FFAR3 are bound and activated by SCFAs.(28,40,41) Importantly, there appears to be a relative selectivity of FFAR2 and FFAR3 for different SCFAs based on the size of the aliphatic tail.”
InfluentialDahiya, D. K., Renuka, Puniya, M., Shandilya, U. K., Dhewa, T., Kumar, N., Kumar, S., Puniya, A. K., & Shukla, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00563 · Cited by 352
“FFAR3 is mainly triggered by the presence of propionate, followed by butyrate and acetate, whereas FFAR2 is stimulated by all three SCFAs at the same rate (Brown et al., 2003).”
BackgroundA review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate
Fung, K. Y. C., Cosgrove, L., Lockett, T., Head, R., & Topping, D. L. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001948 · Cited by 360
“The GPR40 family comprises receptors for SCFA and medium-chain fatty acids, with GPR41 and GPR43 having the highest affinity for SCFA ( , 5 carbons) (80–82) .”
BackgroundPuddu, A., Sanguineti, R., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/162021 · Cited by 342
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
Santana, P. T., Rosas, S. L. B., Ribeiro, B. E., Marinho, Y., & de Souza, H. S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073464 · Cited by 325
van der Beek, C. M., Dejong, C. H. C., Troost, F. J., Masclee, A. A. M., & Lenaerts, K. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw067 · Cited by 343
The gut microbiota in obesity and weight management: microbes as friends or foe?
Van Hul, M., & Cani, P. D. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00794-0 · Cited by 318
Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
Chambers, E. S., Morrison, D. J., & Frost, G. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001657 · Cited by 342
“FFAR2 couples to both Gi/o- (pertussis toxin-sensitive) and Gq-proteins (pertussis toxin-insensitive), whereas FFAR3 couples only to Gi/o-proteins (29,30).”
BackgroundInfluentialGut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
He, M., & Shi, B. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0183-1 · Cited by 336
“FFAR2 was primarily activated by acetate and propionate, whereas FFAR3 was more often activated by propionate and butyrate [98].”
A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology
Chen, H., Nwe, P.-K., Yang, Y., Rosen, C. E., Bielecka, A. A., Kuchroo, M., Cline, G. W., Kruse, A. C., Ring, A. M., Crawford, J. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.036 · Cited by 344
Zaibi, M. S., Stocker, C. J., O'Dowd, J., Davies, A., Bellahcene, M., Cawthorne, M. A., Brown, A. J. H., Smith, D. M., & Arch, J. R. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.027 · Cited by 340
“EC50 values in the range of 35–431 lM have been reported for activation of the human cloned GPR43 by acetate, whilst values in the range 1020–1070 lM have been reported for activation of human cloned GPR41 by acetate [1,3].”
BackgroundInfluentialSelf-citationThe impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology
Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347
Expression of short-chain fatty acid receptor GPR41 in the human colon
Tazoe, H., Otomo, Y., Karaki, S.-I., Kato, I., Fukami, Y., Terasaki, M., & Kuwahara, A. (2009) · Biomedical Research · doi:10.2220/biomedres.30.149 · Cited by 333
Expression of the short-chain fatty acid receptor, GPR43, in the human colon
Karaki, S.-I., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., & Kuwahara, A. (2008) · Journal of Molecular Histology · doi:10.1007/s10735-007-9145-y · Cited by 336
“GPR43 has been reported to couple with Gq and Gi/o proteins to increase intracellular Ca2+ and to decrease cAMP concentrations (Brown et al. 2003; Le Poul et al. 2003).”
How gut microbes talk to organs: The role of endocrine and nervous routes
Cani, P. D., & Knauf, C. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.011 · Cited by 321
“identified the endogenous ligand of these receptors [14].”
BackgroundLoss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Tang, C., Ahmed, K., Gille, A., Lu, S., Gröne, H.-J., Tunaru, S., & Offermanns, S. (2015) · Nature Medicine · doi:10.1038/nm.3779 · Cited by 334
Inflammation in Renal Diseases: New and Old Players
Andrade-Oliveira, V., Foresto-Neto, O., Watanabe, I. K. M., Zatz, R., & Câmara, N. O. S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01192 · Cited by 330
Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity
Chun, E., Lavoie, S., Fonseca-Pereira, D., Bae, S., Michaud, M., Hoveyda, H. R., Fraser, G. L., Gallini Comeau, C. A., Glickman, J. N., Fuller, M. H., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.014 · Cited by 336
“influx eliciting intracellular signaling that regulates numerous cell-specific functions (Brown et al., 2003; Le Poul et al., 2003; Nilsson et al., 2003).”
BackgroundStoddart, L. A., Smith, N. J., & Milligan, G. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00802 · Cited by 334
“Because of the high sequence homology between FFA2 and FFA3, Brown et al. (2003) and Le Poul et al. (2003) also demonstrated that SCFAs were agonists at FFA3.”
BackgroundMethodInfluentialProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders
Yoo, J., & Kim, S. (2016) · Nutrients · doi:10.3390/nu8030173 · Cited by 328
“FFAR2 is primarily activated by acetate and propionate, whereas FFAR3 is more often activated by propionate and butyrate [99].”
BackgroundSerum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome
Shin, J.-H., Park, Y.-H., Sim, M., Kim, S.-A., Joung, H., & Shin, D.-M. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2019.03.003 · Cited by 334
“by intestinal microbes can have signaling functions and can induce receptor-mediated effects like leptin signaling [6,7].”
BackgroundEmergent Sources of Prebiotics: Seaweeds and Microalgae
De Jesus Raposo, M., De Morais, A., & De Morais, R. (2016) · Marine Drugs · doi:10.3390/md14020027 · Cited by 331
Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex
Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.008 · Cited by 331
The metabolic fate of acetate in cancer
Schug, Z. T., Vande Voorde, J., & Gottlieb, E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.87 · Cited by 331
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170014 · Cited by 266
“Activation of these receptors decreases cellular levels of cAMP and increases intracellular Ca 2+ , which serve as second messengers to elicit biological effects (14,69,71,78,109,115,126,133).”
The Gut Microbiome Influences Host Endocrine Functions
Rastelli, M., Cani, P. D., & Knauf, C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00280 · Cited by 307
Davenport, A. P., Alexander, S. P. H., Sharman, J. L., Pawson, A. J., Benson, H. E., Monaghan, A. E., Liew, W. C., Mpamhanga, C. P., Bonner, T. I., Neubig, R. R., et al. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007179 · Cited by 327
Lipid alterations in chronic liver disease and liver cancer
Paul, B., Lewinska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 308
Microbiome therapeutics — Advances and challenges
Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317
Metadata
- Authors
- Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., Pike, N. B., Strum, J. C., Steplewski, K. M., Murdock, P. R., Holder, J. C., Marshall, F. H., Szekeres, P. G., Wilson, S., Ignar, D. M., Foord, S. M., Wise, A., & Dowell, S. J.
- Affiliations
- Research Triangle Park Foundation (US)
- Corresponding author
- Brown, Andrew J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11312-11319
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035421462
- Cited by
- 2,409
- References
- 33
- Citations by year
- 2026: 164 · 2025: 167 · 2024: 140 · 2023: 174 · 2022: 179 · 2021: 184 · 2020: 172 · 2019: 153 · 2018: 149 · 2017: 99 · 2016: 150 · 2015: 114 · 2014: 95 · 2013: 86 · 2012: 86
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6422 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- GPR41, GPR43, orphan G protein-coupled receptor, propionate, short-chain carboxylic acids, acetate, receptor agonists, gene duplication, pseudogenes, adipose tissue, immune cells, ligand identification
- MeSH terms
- Amino Acid Sequence, Animals, Carboxylic Acids, Humans, Immunohistochemistry, Molecular Sequence Data, Propionates, Receptors, Cell Surface, Recombinant Proteins, Xenopus laevis, DNA Primers, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.